Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fecal Transplant for Alopecia Areata
NCT04833179Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- May 2021
- Primary completion
- Apr 2024
- Modality
- Live Biotherapeutic Products
01
Overview
Randomised, double-blind trial of Fecal Microbiota Transplantation Capsule in alopecia areata (2 arms), sponsored by Tel Aviv Sourasky Medical Center. Primary endpoints: Severity Alopecia Tool Score at 1 year, Alopecia Areata Progression Index at 1 year and 1 more. Status: unknown.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT04833179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04833179.